Cargando…
A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733313/ https://www.ncbi.nlm.nih.gov/pubmed/35000737 http://dx.doi.org/10.1016/j.jaip.2021.10.063 |
| _version_ | 1784627776374964224 |
|---|---|
| author | Maeda, Yohei Yoshioka, Takashi Hayama, Masaki Inohara, Hidenori |
| author_facet | Maeda, Yohei Yoshioka, Takashi Hayama, Masaki Inohara, Hidenori |
| author_sort | Maeda, Yohei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8733313 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87333132022-01-06 A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter Maeda, Yohei Yoshioka, Takashi Hayama, Masaki Inohara, Hidenori J Allergy Clin Immunol Pract Correspondence and Reply American Academy of Allergy, Asthma & Immunology 2022-01 2022-01-06 /pmc/articles/PMC8733313/ /pubmed/35000737 http://dx.doi.org/10.1016/j.jaip.2021.10.063 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence and Reply Maeda, Yohei Yoshioka, Takashi Hayama, Masaki Inohara, Hidenori A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter |
| title | A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter |
| title_full | A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter |
| title_fullStr | A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter |
| title_full_unstemmed | A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter |
| title_short | A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter |
| title_sort | limitation regarding the association between intranasal corticosteroid use and better covid-19 outcomes: nasal symptoms matter |
| topic | Correspondence and Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733313/ https://www.ncbi.nlm.nih.gov/pubmed/35000737 http://dx.doi.org/10.1016/j.jaip.2021.10.063 |
| work_keys_str_mv | AT maedayohei alimitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT yoshiokatakashi alimitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT hayamamasaki alimitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT inoharahidenori alimitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT maedayohei limitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT yoshiokatakashi limitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT hayamamasaki limitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT inoharahidenori limitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter |